NCT06055868 People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
| NCT ID | NCT06055868 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | HIV Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 144 participants |
| Start Date | 2025-02-13 |
| Primary Completion | 2029-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 144 participants in total. It began in 2025-02-13 with a primary completion date of 2029-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.
Eligibility Criteria
Inclusion Criteria: * Participants must be 18-years old or older. * Participants must be individuals living with HIV * Ability to speak and understand English * Identify as one or more racial/ethnic minority groups or sexual and gender minority groups * All genders and members of all races and ethnic groups are eligible for this study. Exclusion Criteria: * Younger than 18-years old. * Not living with HIV. * Not able to speak and understand English. * Not classified as one or more racial/ethnic minority groups or sexual and gender minority groups.
Contact & Investigator
Alexandra Hernandez Levenston, PhD, MPH
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06055868 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06055868 currently recruiting?
Yes, NCT06055868 is actively recruiting participants. Contact the research team at William.Juarez@ucsf.edu for enrollment information.
Where is the NCT06055868 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06055868 clinical trial?
NCT06055868 is sponsored by University of California, San Francisco. The principal investigator is Alexandra Hernandez Levenston, PhD, MPH at University of California, San Francisco. The trial plans to enroll 144 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.